Evidence map›Paper›PMID 34637655›Full record

ReviewOpen biology2021

Malaria, COVID-19 and angiotensin-converting enzyme 2: what does the available population data say?

A De, M Dash, A Tiwari, A Sinha

Abstract readReview
In one paragraph

Review in Open biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

A DeICMR-National Institute of Malaria Research, New Delhi, India.ORCID 0000-0002-8082-7862
M DashICMR-National Institute of Malaria Research, New Delhi, India.ORCID 0000-0001-6987-7239
A TiwariICMR-National Institute of Malaria Research, New Delhi, India.ORCID 0000-0003-0663-3362
A SinhaICMR-National Institute of Malaria Research, New Delhi, India.ORCID 0000-0003-1900-7686

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The etiopathogenesis of COVID-19 and its differential geographic spread suggest some populations are apparently 'less affected' through many host-related factors that involve angiotensin-converting enzyme 2 (ACE2) protein, which is also the entry receptor for SARS-CoV-2. The role of ACE2 has been well studied in COVID-19 but not in the context of malaria and COVID-19. We have previously suggested how malaria might intersect with COVID-19 through

Indexed as

AllelesAngiotensin-Converting Enzyme 2COVID-19Genetic Predisposition to DiseaseGenetic VariationGeographyGlobal HealthHumansIndiaMalariaMutationACE2 protein, humanAngiotensin-Converting Enzyme 2ACE2COVID-19malaria

Identifiers

PMID34637655
PMCPMC8510699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.